Studies have shown that active fund managers routinely underperform the S&P500 index*​

NeoGenomics, Inc. (NASDAQ: NEO)

NEO Stock Predictions and Ratings

WSX Rating:
HOLD
WSX Forecast (1yr):
4.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
32.40%

NEO Stock Analysis

NEO PE Ratio:

NEO PEG Ratio:

NEO Forward EPS Growth (12 month): 89.20%

NEO PS Ratio: 0.4

NEO PSG Ratio:

NEO Forward Revenue Growth (12 month): 10.00%

NEO Articles

No data was found